Raymond James & Associates »

Dexcom shares owned by Raymond James & Associates

Quarter-by-quarter ownership of Dexcom shares owned by Raymond James & Associates from 13F filings

Historical chart of Raymond James & Associates investment in Dexcom

Tip: Access up to 7 years of quarterly data

All positions including Dexcom held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dexcom by Raymond James & Associates

Quarter filed Position value Share count Share price at filing
2024-09-30 $47k 49k 0.95
2024-06-30 $46k 46k 1.00
2022-09-30 $16k 17k 0.94

More positions owned by Raymond James & Associates

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Us Aggbd Et (AGG)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p Mcp Etf (IJH)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Home Depot (HD)
UnitedHealth (UNH)

View all positions for Raymond James & Associates

Top funds holding Dexcom

Ing Investment Management
Tenor Capital Management
Lazard Asset Management
Braidwell
Steelhead Partners
Two Sigma Investments
Calamos Advisors
MacKay Shields
Franklin Resources
State Street Corporation
Hudson Bay Capital Management
Pier 88 Investment Partners
Susquehanna International
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
BlackRock

View all funds holding Dexcom